[go: up one dir, main page]

ATE235478T1 - Verfahren zur herstellung von citalopram - Google Patents

Verfahren zur herstellung von citalopram

Info

Publication number
ATE235478T1
ATE235478T1 AT99968622T AT99968622T ATE235478T1 AT E235478 T1 ATE235478 T1 AT E235478T1 AT 99968622 T AT99968622 T AT 99968622T AT 99968622 T AT99968622 T AT 99968622T AT E235478 T1 ATE235478 T1 AT E235478T1
Authority
AT
Austria
Prior art keywords
producing citalopram
citalopram
producing
Prior art date
Application number
AT99968622T
Other languages
English (en)
Inventor
Hans Petersen
Michael Harold Rock
Henrik Svane
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of ATE235478T1 publication Critical patent/ATE235478T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44Palladium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
AT99968622T 1999-06-25 1999-11-22 Verfahren zur herstellung von citalopram ATE235478T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900920 1999-06-25
PCT/DK1999/000640 WO2000013648A2 (en) 1999-06-25 1999-11-22 Method for the preparation of citalopram

Publications (1)

Publication Number Publication Date
ATE235478T1 true ATE235478T1 (de) 2003-04-15

Family

ID=8099035

Family Applications (3)

Application Number Title Priority Date Filing Date
AT0904199A AT409961B (de) 1999-06-25 1999-11-22 Verfahren zur herstellung von citalopram
AT99968622T ATE235478T1 (de) 1999-06-25 1999-11-22 Verfahren zur herstellung von citalopram
AT0018401U AT4365U1 (de) 1999-06-25 2001-03-13 Verfahren zur herstellung von citalopram

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0904199A AT409961B (de) 1999-06-25 1999-11-22 Verfahren zur herstellung von citalopram

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT0018401U AT4365U1 (de) 1999-06-25 2001-03-13 Verfahren zur herstellung von citalopram

Country Status (36)

Country Link
US (2) US20020077353A1 (de)
EP (1) EP1159274B1 (de)
JP (1) JP3447267B2 (de)
KR (1) KR100491368B1 (de)
CN (2) CN1140521C (de)
AR (1) AR020863A1 (de)
AT (3) AT409961B (de)
AU (2) AU1374500A (de)
BG (1) BG65574B1 (de)
BR (1) BR9917368B1 (de)
CA (2) CA2290127C (de)
CH (1) CH691305A5 (de)
CZ (1) CZ292198B6 (de)
DE (2) DE69906389T2 (de)
DK (2) DK1159274T3 (de)
EA (1) EA002560B1 (de)
ES (2) ES2194545T3 (de)
FI (1) FI108641B (de)
GB (2) GB2357761B (de)
HK (1) HK1049002B (de)
HU (1) HUP0103235A3 (de)
IL (2) IL145959A0 (de)
IS (1) IS2343B (de)
IT (1) ITMI991581A1 (de)
MX (1) MXPA01010989A (de)
NO (1) NO328542B1 (de)
NZ (1) NZ514979A (de)
PL (1) PL205579B1 (de)
PT (1) PT1159274E (de)
SE (1) SE516690C2 (de)
SI (1) SI1159274T1 (de)
SK (1) SK285813B6 (de)
TR (1) TR200103702T2 (de)
UA (1) UA63034C2 (de)
WO (1) WO2000013648A2 (de)
ZA (1) ZA200108854B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100454008B1 (ko) 1998-12-23 2004-10-20 하. 룬트벡 아크티에 셀스카브 5-시아노프탈리드의 제조방법
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
SI1173431T2 (sl) 1999-04-14 2009-12-31 Lundbeck & Co As H Postopek za pripravo citaloprama
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
TR200101874T1 (tr) 1999-10-25 2002-02-21 H. Lundbeck A/S Sitalopram hazırlanması için yöntem
HUP0200169A3 (en) 1999-10-25 2002-11-28 Lundbeck & Co As H Method for the preparation of citalopram
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
SI1246812T1 (en) 1999-12-28 2004-08-31 H. Lundbeck A/S Method for the preparation of citalopram
SI1246813T1 (en) 1999-12-30 2004-08-31 H. Lundbeck A/S Method for the preparation of citalopram
CZ20022601A3 (cs) 2000-01-14 2002-10-16 H. Lundbeck A/S Způsob výroby 5-kyanoftalidu
FR2805812A1 (fr) 2000-02-24 2001-09-07 Lundbeck & Co As H Procede de preparation du citalopram
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
TR200202195T2 (tr) 2000-03-13 2002-12-23 H. Lundbeck A/S 5-Yer değiştirmiş 1-(4-florofenil)-1,3- dihidroizobenzofuran'ın adım adım alkillenmesi
NZ521201A (en) 2000-03-13 2004-02-27 H Method for the preparation of citalopram
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
PL360107A1 (en) 2000-03-14 2004-09-06 H.Lundbeck A/S Method for the preparation of citalopram
WO2001068632A1 (en) * 2000-03-16 2001-09-20 H. Lundbeck A/S Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
CZ2002832A3 (cs) * 2000-07-06 2002-05-15 H. Lundbeck A/S Způsob výroby citalopramu
IL144816A (en) * 2000-08-18 2005-09-25 Lundbeck & Co As H Method for the preparation of citalopram
ES2228824T3 (es) * 2000-12-22 2005-04-16 H. Lundbeck A/S Metodo de preparacion de citalopram puro.
ATE222899T1 (de) * 2000-12-28 2002-09-15 Lundbeck & Co As H Verfahren zur herstellung von reinem citalopram
EP1355897A1 (de) 2001-01-30 2003-10-29 Orion Corporation Fermion Verfahren zur herstellung von 1-(3-dimethylaminopropyl)-1-(4-fluorphenyl)-1,3-dihydrobenzofuran-5-carbonitrile
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
WO2002072565A1 (en) * 2001-03-09 2002-09-19 Ranbaxy Laboratories Limited Process for the preparation of citalopram
US6967259B2 (en) * 2001-09-24 2005-11-22 Pharmachem Technologies Limited Process for the preparation of Citalopram intermediate
WO2003057132A2 (en) * 2002-01-07 2003-07-17 Sun Pharmaceutical Industries Limited Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
AR040970A1 (es) 2002-08-12 2005-04-27 Lundbeck & Co As H Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram
WO2004085416A1 (en) * 2003-03-24 2004-10-07 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
US7019153B2 (en) 2003-06-10 2006-03-28 Sun Pharmaceutical Industries Limited Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
KR101166280B1 (ko) 2004-08-23 2013-11-27 썬 파마 글로벌 에프제트이 시탈로프램 및 에난티오머의 제조 방법
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EP2017271A1 (de) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Verfahren zur Herstellung von Escitalopram
CN114763343B (zh) * 2021-01-14 2026-02-10 浙江华海药业股份有限公司 一种西酞普兰或s-西酞普兰的纯化方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143702A (de) * 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
DK213290D0 (da) * 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DE19626659A1 (de) * 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) * 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
DK1015416T3 (da) * 1997-07-08 2001-11-05 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
SK283907B6 (sk) * 1997-11-11 2004-04-06 H. Lundbeck A/S Spôsob výroby citalopramu a medziprodukty
ES2189502T3 (es) * 1998-10-20 2003-07-01 Lundbeck & Co As H Metodo para la prevencion de citalopram.
KR100454008B1 (ko) * 1998-12-23 2004-10-20 하. 룬트벡 아크티에 셀스카브 5-시아노프탈리드의 제조방법
AR022329A1 (es) * 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
SI1173431T2 (sl) * 1999-04-14 2009-12-31 Lundbeck & Co As H Postopek za pripravo citaloprama
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
TR200101874T1 (tr) * 1999-10-25 2002-02-21 H. Lundbeck A/S Sitalopram hazırlanması için yöntem
AR026063A1 (es) * 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
FR2805812A1 (fr) * 2000-02-24 2001-09-07 Lundbeck & Co As H Procede de preparation du citalopram
IES20010143A2 (en) * 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
IL144816A (en) * 2000-08-18 2005-09-25 Lundbeck & Co As H Method for the preparation of citalopram
ES2228824T3 (es) * 2000-12-22 2005-04-16 H. Lundbeck A/S Metodo de preparacion de citalopram puro.
ATE222899T1 (de) * 2000-12-28 2002-09-15 Lundbeck & Co As H Verfahren zur herstellung von reinem citalopram

Also Published As

Publication number Publication date
WO2000013648A2 (en) 2000-03-16
NZ514979A (en) 2004-01-30
PT1159274E (pt) 2003-08-29
GB0101504D0 (en) 2001-03-07
SE0100193L (sv) 2001-04-25
EA002560B1 (ru) 2002-06-27
AT409961B (de) 2002-12-27
BR9917368B1 (pt) 2010-02-09
CH691305A5 (de) 2001-06-29
AU1374500A (en) 2000-03-27
TR200103702T2 (tr) 2002-06-21
DK1159274T3 (da) 2003-07-21
CA2475401A1 (en) 2000-12-25
BR9917368A (pt) 2002-03-05
ZA200108854B (en) 2002-08-28
CN1140521C (zh) 2004-03-03
JP3447267B2 (ja) 2003-09-16
IS2343B (is) 2008-02-15
GB2357761B (en) 2001-09-05
ES2194545T3 (es) 2003-11-16
IS5861A (is) 2001-02-23
GB2354239B (en) 2001-06-06
CN1502616A (zh) 2004-06-09
AU2001100440B4 (en) 2002-01-24
DE69906389T2 (de) 2003-10-30
DK200100060A (da) 2001-04-10
HUP0103235A3 (en) 2003-01-28
EP1159274B1 (de) 2003-03-26
AT4365U1 (de) 2001-06-25
US20020077353A1 (en) 2002-06-20
WO2000013648B1 (en) 2001-03-15
DE19983487C1 (de) 2002-07-25
CZ2001320A3 (en) 2001-05-16
ITMI991581A0 (it) 1999-07-15
DE69906389D1 (de) 2003-04-30
WO2000013648A8 (en) 2000-05-11
ITMI991581A1 (it) 2001-01-15
EA200101072A1 (ru) 2002-02-28
NO20010319L (no) 2001-02-23
SI1159274T1 (en) 2003-10-31
WO2000013648A3 (en) 2000-07-13
FI108641B (fi) 2002-02-28
CA2290127A1 (en) 2000-12-25
JP2002526386A (ja) 2002-08-20
SE0100193D0 (sv) 2001-01-24
IL145959A (en) 2007-07-24
NO328542B1 (no) 2010-03-15
IL145959A0 (en) 2002-07-25
NO20010319D0 (no) 2001-01-19
BG65574B1 (bg) 2009-01-30
HK1049002B (zh) 2004-12-31
SE516690C2 (sv) 2002-02-12
HK1049002A1 (en) 2003-04-25
GB2357761A (en) 2001-07-04
EP1159274A2 (de) 2001-12-05
PL346237A1 (en) 2002-01-28
MXPA01010989A (es) 2002-06-04
HUP0103235A2 (hu) 2002-01-28
AR020863A1 (es) 2002-05-29
ATA904199A (de) 2002-05-15
AU2001100440A4 (en) 2001-11-01
KR20020012204A (ko) 2002-02-15
KR100491368B1 (ko) 2005-05-24
CA2290127C (en) 2005-01-25
SK285813B6 (sk) 2007-08-02
PL205579B1 (pl) 2010-05-31
SK18402001A3 (sk) 2002-06-04
CZ292198B6 (cs) 2003-08-13
ES2189699A1 (es) 2003-07-01
BG106191A (en) 2002-08-30
US20090088469A1 (en) 2009-04-02
CN1367786A (zh) 2002-09-04
GB0105182D0 (en) 2001-04-18
FI20010155L (fi) 2001-02-09
GB2354239A (en) 2001-03-21
UA63034C2 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
DE69907037T2 (de) Verfahren zur herstellung von citalopram
ATE213237T1 (de) Verfahren zur herstellung von citalopram
ATE235478T1 (de) Verfahren zur herstellung von citalopram
DE69904853D1 (de) Verfahren zur herstellung von citalopram
ATE363476T1 (de) Verfahren zur herstellung von furfural
DE69719098D1 (de) Verfahren zur herstellung von citalopram
DE60000364D1 (de) Verfahren zur herstellung von 5-cyanophthalid
ATE281448T1 (de) Verfahren zur herstellung von citalopram
DE60100016D1 (de) Verfahren zur herstellung von reinem citalopram
DE69906580D1 (de) Verfahren zur herstellung von 5-cyanophthalid
DE69908824D1 (de) Verfahren zur herstellung von bisphenol-a
DE60003264D1 (de) Verfahren zur herstellung von glycerylethern
ATE389645T1 (de) Verfahren zur herstellung von citalopram
DE50006772D1 (de) Verfahren zur herstellung von oxindolen
DE59901552D1 (de) Verfahren zur herstellung von polyalkylenarylaten
ATE277032T1 (de) Verfahren zur herstellung von citalopram
EP1208106A4 (de) Verfahren zur herstellung von aminopropyl- oder aminoalkyl-unktionalisierten polyalkyl- oder aryl-siloxanen
DE60107061D1 (de) Verfahren zur herstellung von citalopram
DE50001895D1 (de) Verfahren zur herstellung von phosphonomethylglycin
DE60004834D1 (de) Verfahren zur herstellung von mikrokapseln
ATE233238T1 (de) Verfahren zur herstellung von 3-acyl-indolen
DE50002773D1 (de) Verfahren zur herstellung von hydroxymethylpyridinen
DE60011427D1 (de) Verfahren zur herstellung von 2-pyridylpiperidin-derivaten
DE50004440D1 (de) Verfahren zur herstellung von phosphonomethylglycin
DE60009060D1 (de) Verfahren zur herstellung von 2-pyridylpyridin-derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1159274

Country of ref document: EP

REN Ceased due to non-payment of the annual fee